Skip to main content
. 2015 Jul 6;4(8):474–480. doi: 10.1002/psp4.53

Table 5.

Top 6 drug combinations showing increased risk, based on LFDR values

Drug_1 Drug_2 Drug_3 Drug_4 Drug_5 Drug_6 Sample size Inline graphic Risk
Acetaminophen Alprazolam Duloxetine Oxycodone Hydrocodone Zolpidem 66 17.699 0.485
Acetaminophen Duloxetine Oxycodone Hydrocodone Zolpidem Tramadol 42 14.013 0.548
Acetaminophen Alprazolam Oxycodone Hydrocodone Zolpidem Tramadol 57 13.030 0.439
Acetaminophen Alprazolam Duloxetine Oxycodone Hydrocodone Tramadol 53 10.150 0.396
Acetaminophen Alprazolam Duloxetine Oxycodone Zolpidem Tramadol 24 10.115 0.625
Simvastatin Acetaminophen Alprazolam Duloxetine Oxycodone Hydrocodone 36 9.692 0.472
Acetaminophen Alprazolam Duloxetine Hydrocodone Zolpidem Tramadol 41 9.666 0.439
Alprazolam Duloxetine Oxycodone Hydrocodone Zolpidem Tramadol 18 7.607 0.611
Simvastatin Acetaminophen Duloxetine Oxycodone Hydrocodone Zolpidem 34 7.345 0.412
Acetaminophen Duloxetine Oxycodone Hydrocodone Zolpidem Fluoxetine 32 6.811 0.406

Bold drugs are reported for myopathy in SIDER 2.